GO:1902483 cytotoxic T cell pyroptotic cell death: Mechanism, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:1902483 describes a pyroptotic cell death process that occurs specifically in cytotoxic T cells, a regulated lytic death driven by gasdermin pore formation.
• Granzymes delivered by cytotoxic lymphocytes cleave gasdermin substrates such as GSDMB and GSDME to trigger pyroptosis in target cells, and similar machinery operates in cytotoxic T cells themselves.
• GSDME (DFNA5) is a central executioner: its cleavage releases an N-terminal pore-forming fragment that permeabilizes membranes and drives pyroptotic death.
• Pyroptosis in cytotoxic T cells and their targets shapes anti-tumour immunity, autoimmune liver injury, pregnancy loss and infection control.
• The process is regulated by immune checkpoints such as PD-1 and by granzyme/gasdermin balances, making it a target for immunotherapy research.
• CRISPR knockout, point-mutation, knock-in and overexpression models are essential to dissect which gasdermin and granzyme genes causally control cytotoxic T cell pyroptotic death.
Description
GO:1902483, cytotoxic T cell pyroptotic cell death, is a biological process defined as a pyroptotic cell death process that occurs in a cytotoxic T cell. Pyroptosis is a lytic, inflammatory form of regulated cell death executed by gasdermin family proteins, and its occurrence in cytotoxic T cells has emerged as a critical determinant of immune responses. Cytotoxic T cells, including CD8+ T lymphocytes, are traditionally viewed as killers of infected or transformed cells, but they can themselves undergo pyroptotic death under specific conditions, influencing the outcome of anti-tumour and autoimmune responses. Understanding this process is important because it links lymphocyte biology to gasdermin-mediated membrane pore formation, inflammatory cytokine release and immune homeostasis. The term is closely related to granzyme-mediated killing: cytotoxic lymphocytes deliver granzymes into target cells, where granzyme A cleaves GSDMB and granzyme B can activate GSDME, triggering pyroptosis in the target. In cytotoxic T cells themselves, similar gasdermin-dependent pathways can be engaged, and the balance between survival and pyroptotic death affects the magnitude and duration of immune responses. Recent studies show that PD-1+CD8+ T cell-mediated hepatocyte pyroptosis promotes autoimmune liver disease progression, illustrating how cytotoxic T cell-associated pyroptosis contributes to pathology. For researchers, GO:1902483 provides a precise ontology handle to annotate genes, design CRISPR screens and interpret single-cell or spatial transcriptomics data involving cytotoxic T cell death. Because the process intersects with cancer immunotherapy, autoimmunity, infection and reproductive immunology, it is a high-value target for mechanistic and translational studies.
cytotoxic T cell pyroptotic cell death At A Glance
| GO ID | GO:1902483 |
|---|---|
| GO term | cytotoxic T cell pyroptotic cell death |
| Ontology | biological_process |
| Synonym | cytotoxic T cell apoptosis; cytotoxic T-cell apoptosis; cytotoxic T cell apoptotic process; cytotoxic T-cell programmed cell death; cytotoxic T cell pyroptotic process; cytotoxic T lymphocyte apoptotic process |
| Major function | Execution of gasdermin-dependent lytic cell death in cytotoxic T cells, contributing to immune regulation and inflammation |
| Related cell type | Cytotoxic T cells, including CD8+ T lymphocytes |
| Key executioners | Gasdermin family proteins such as GSDME and GSDMB, activated by granzymes |
| Disease relevance | Cancer immunity, autoimmune liver disease, pregnancy loss and infection |
| Research methods | CRISPR knockout/knock-in, flow cytometry, live-cell imaging, cytokine profiling, transcriptomics |
What Is GO:1902483?
In our own words, GO:1902483 refers to the execution of pyroptotic cell death specifically within a cytotoxic T cell. Pyroptosis is a programmed lytic death that depends on gasdermin proteins forming pores in the plasma membrane, leading to cell swelling, membrane rupture and release of inflammatory contents. When this program is activated in cytotoxic T cells, it is annotated as cytotoxic T cell pyroptotic cell death. The term is a child of pyroptotic cell death and is restricted by cell type to cytotoxic T cells, distinguishing it from pyroptosis in macrophages, epithelial cells or other targets.
Why Is cytotoxic T cell pyroptotic cell death Important in Cell Biology?
Cytotoxic T cell pyroptotic cell death is important because it determines whether cytotoxic T cells survive to kill targets or die themselves, thereby shaping the intensity and duration of immune responses. Gasdermin-mediated pyroptosis in these cells releases inflammatory mediators that can amplify anti-tumour immunity but also drive tissue damage in autoimmunity. Understanding GO:1902483 helps researchers interpret immunotherapy outcomes, design safer cell therapies and identify biomarkers of immune-related adverse events.
• Controls the lifespan of cytotoxic T cells, affecting the magnitude of adaptive immune responses.
• Links granzyme biology to gasdermin pore formation in lymphocytes and their targets.
• Shapes anti-tumour immunity, as GSDME activation in tumour and immune compartments can suppress or promote tumour growth.
• Contributes to autoimmune liver disease through PD-1+CD8+ T cell-mediated hepatocyte pyroptosis.
• Is implicated in early pregnancy loss via altered decidual CD8+ T cell immune function.
• Plays a role in host defence against intestinal Salmonella infection through distinct granzyme-induced death pathways.
• Provides a mechanistic basis for combining pyroptosis inducers with immunotherapy in pancreatic cancer models.
• Offers CRISPR-tractable targets (GSDME, GSDMB, granzymes) for functional validation.
• Helps explain immune-related adverse events and resistance to checkpoint blockade.
• Supports development of biomarkers and therapeutic strategies targeting regulated cell death in T cells.
What Happens During cytotoxic T cell pyroptotic cell death?
Initiation by granzyme and gasdermin activation
In simple terms: Killer enzymes from other immune cells cut a protein that punches holes in the T cell membrane.
Pyroptosis in cytotoxic T cells can be initiated when granzymes, such as granzyme A or granzyme B, enter the cell and cleave gasdermin substrates. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells, and similar granzyme-gasdermin axes can operate in cytotoxic T cells themselves. Granzyme B can activate GSDME by cleavage, releasing an N-terminal fragment that forms membrane pores. This initiation step is a key control point and is influenced by the local inflammatory milieu and immune checkpoint signals.
Gasdermin pore formation and membrane permeabilization
In simple terms: The cut protein piece inserts into the membrane and makes holes, causing the cell to swell and burst.
Once cleaved, the N-terminal gasdermin fragment oligomerizes and inserts into the plasma membrane, forming large pores. GSDME-mediated pore formation is a central executioner step in pyroptotic death, and its activation in cytotoxic T cells leads to loss of ionic gradients, water influx and cell swelling. GSDMB cleavage by granzyme A similarly triggers pyroptosis in target cells, demonstrating the generality of gasdermin pore formation in this process. The pores also allow release of inflammatory cytokines such as IL-1β and IL-18, amplifying immune signalling.
Inflammatory cytokine release and immune amplification
In simple terms: When the cell bursts, it spills signals that call more immune cells to the area.
Pyroptotic death is inherently inflammatory. In cytotoxic T cell pyroptotic death, membrane rupture releases damage-associated molecular patterns and cytokines, which can recruit and activate additional immune cells. This amplification loop is beneficial for anti-tumour immunity but can exacerbate autoimmune tissue damage, as seen in PD-1+CD8+ T cell-mediated hepatocyte pyroptosis in murine autoimmune liver disease. Clofarabine-induced GSDME-related pyroptosis and CD8+ T-cell antitumour activity further illustrate how pyroptosis in the T cell compartment can enhance immunotherapy.
Regulation by immune checkpoints and metabolic cues
In simple terms: Brakes on immune cells, like PD-1, and metabolic signals decide whether the cell dies this way.
The PD-1 checkpoint modulates CD8+ T cell activity and can influence pyroptosis-related tissue damage; PD-1+CD8+ T cells mediate hepatocyte pyroptosis in autoimmune liver disease. Metabolic and stress signals also intersect with pyroptosis: arachidonic acid induces pyroptosis via a non-autophagic function of mitophagy and enhances immunotherapy in a PDAC model. These regulatory inputs determine whether cytotoxic T cells survive, die by pyroptosis, or switch to other death modalities.
Outcomes: target killing versus self-death
In simple terms: The same hole-punching machinery can kill the target cell or the T cell itself.
In cytotoxic T cell biology, gasdermin activation can occur in the target cell, leading to target pyroptosis, or in the cytotoxic T cell itself, leading to self-death annotated as GO:1902483. Distinct cell death pathways induced by granzymes collectively protect against intestinal Salmonella infection, showing that the balance between apoptosis and pyroptosis in lymphocytes and targets affects infection control. In early pregnancy loss, decidual CD11c+CD8+ T cells show altered immune function, suggesting that dysregulated cytotoxic T cell death contributes to reproductive failure.
Key Genes Involved in GO:1902483 cytotoxic T cell pyroptotic cell death
The following genes and proteins are central to cytotoxic T cell pyroptotic cell death, based on published functional studies.
| Gene | Major Role | Research Relevance |
|---|---|---|
| GSDME (DFNA5) | Gasdermin executioner cleaved to form membrane pores during pyroptosis | Key target for knockout and cleavage-site mutation studies in cytotoxic T cell death |
| GSDMB | Gasdermin substrate cleaved by granzyme A to trigger pyroptosis | Important for granzyme A-mediated pyroptosis in lymphocytes and targets |
| GZMA | Granzyme A serine protease that cleaves GSDMB | Knockout models reveal its role in cytotoxic lymphocyte-induced pyroptosis |
| GZMB | Granzyme B serine protease that can activate GSDME | Central to granzyme-mediated death pathways in infection and immunity |
| PDCD1 (PD-1) | Immune checkpoint receptor regulating CD8+ T cell activity | PD-1+CD8+ T cells mediate hepatocyte pyroptosis in autoimmune liver disease |
| CD8A | Marker of cytotoxic T cells | Used to identify and isolate cytotoxic T cells for pyroptosis assays |
| IL1B | Inflammatory cytokine released during pyroptosis | Readout of pyroptotic inflammatory amplification |
| IL18 | Inflammatory cytokine released during pyroptosis | Biomarker of gasdermin pore formation and immune activation |
| CASP1 | Inflammasome caspase involved in canonical pyroptosis | Context-dependent role in cytotoxic T cell pyroptosis |
| CASP3 | Apoptotic caspase that can cleave GSDME | Links apoptosis to secondary pyroptosis in T cells |
| STING1 | Innate immune adaptor in non-canonical pyroptosis pathways | Clofarabine induces GSDME-related pyroptosis via P53/STING |
| TP53 | Tumour suppressor regulating cell death and immune signalling | Non-canonical P53/STING pathway in pyroptosis induction |
| CD11c (ITGAX) | Integrin marker on a subset of CD8+ T cells | Decidual CD11c+CD8+ T cells show altered immune function in pregnancy loss |
| GSDMD | Gasdermin family member in canonical pyroptosis | Comparative studies of gasdermin usage in lymphocytes |
| HMGB1 | Damage-associated molecular pattern released upon lysis | Marker of pyroptotic membrane rupture |
| LDH | Cytoplasmic enzyme released upon membrane rupture | Common assay readout for pyroptotic death |
How Is cytotoxic T cell pyroptotic cell death Regulated?
Cytotoxic T cell pyroptotic cell death is regulated at multiple levels. Immune checkpoints such as PD-1 modulate CD8+ T cell activity and can influence pyroptosis-mediated tissue damage, as PD-1+CD8+ T cells mediate hepatocyte pyroptosis in autoimmune liver disease. Granzyme expression and delivery determine whether gasdermin substrates are cleaved, with granzyme A and granzyme B targeting GSDMB and GSDME respectively. Metabolic and stress pathways also regulate the process: arachidonic acid induces pyroptosis via a non-autophagic function of mitophagy and enhances immunotherapy in a PDAC model. In addition, the non-canonical P53/STING pathway can drive GSDME-related pyroptosis and CD8+ T-cell antitumour activity. These layers of regulation provide multiple entry points for therapeutic intervention and CRISPR-based dissection.
cytotoxic T cell pyroptotic cell death and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| GSDME | Cancer immunity and tumour suppression | GSDME knockout and cleavage-site mutant knock-in in CD8+ T cells |
| GSDMB | Granzyme A-mediated pyroptosis in infection and immunity | GSDMB knockout in cytotoxic lymphocytes and target cells |
| PDCD1 (PD-1) | Autoimmune liver disease | PD-1 knockout or overexpression in murine CD8+ T cells |
| CD11c (ITGAX) | Early pregnancy loss | Decidual CD8+ T cell models with CD11c knock-in/knockout |
| GZMA/GZMB | Intestinal Salmonella infection | Granzyme knockout mice and intestinal organoid co-culture |
Cancer and anti-tumour immunity
GSDME suppresses tumour growth by activating anti-tumour immunity, and its cleavage in immune and tumour compartments can convert apoptosis to pyroptosis. Clofarabine induces GSDME-related pyroptosis and CD8+ T-cell antitumour activity via the non-canonical P53/STING pathway, highlighting therapeutic opportunities. Arachidonic acid-induced pyroptosis enhances immunotherapy in a PDAC model, further linking this process to cancer treatment.
Autoimmune and inflammatory liver disease
PD-1+CD8+ T cell-mediated hepatocyte pyroptosis promotes progression of murine autoimmune liver disease, demonstrating that cytotoxic T cell-associated pyroptosis can drive organ damage. This suggests that targeting gasdermin or granzyme pathways in T cells may reduce autoimmune pathology.
Pregnancy loss and reproductive immunology
Enrichment of decidual CD11c+CD8+ T cells with altered immune function is observed in early pregnancy loss, implicating cytotoxic T cell death pathways in reproductive failure. Understanding GO:1902483 may inform biomarkers and interventions for pregnancy complications.
Infection and host defence
Distinct cell death pathways induced by granzymes collectively protect against intestinal Salmonella infection, showing that pyroptosis-related death in lymphocytes and targets is important for antibacterial immunity. Hashimoto's thyroiditis involves immune system dysregulation, and cytotoxic T cell death pathways may contribute to thyroid autoimmunity.
From cytotoxic T cell pyroptotic cell death-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does GSDME cleavage drive cytotoxic T cell pyroptosis? | GSDME knockout and cleavage-site point-mutation knock-in in CD8+ T cells |
| Is granzyme A-mediated GSDMB cleavage required for pyroptosis? | GZMA knockout and GSDMB point-mutation knock-in |
| Does PD-1 signaling regulate T cell-mediated hepatocyte pyroptosis? | PD-1 knockout or overexpression in murine autoimmune liver models |
| Can GSDME overexpression enhance anti-tumour immunity? | GSDME overexpression in tumour cells and co-culture with CD8+ T cells |
| What is the role of STING in non-canonical pyroptosis? | STING1 knockout and tagged knock-in for pathway tracing |
| Does arachidonic acid-induced mitophagy regulate pyroptosis? | Mitophagy gene knockout and overexpression in PDAC models |
How to Study the cytotoxic T cell pyroptotic cell death Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Flow cytometry | Cell death, gasdermin cleavage, surface markers | Quantifying pyroptosis in CD8+ T cells |
| LDH release assay | Membrane rupture | Confirming pyroptotic death |
| Live-cell imaging | Gasdermin pore formation and membrane dynamics | Visualizing pyroptosis in real time |
| RNA sequencing | Transcriptional changes during pyroptosis | Identifying pathways and biomarkers |
| Cytokine profiling | IL-1β and IL-18 release | Measuring inflammatory amplification |
| CRISPR knockout screening | Genes required for pyroptosis | Functional genomics of cytotoxic T cell death |
| Co-culture assays | T cell-mediated target pyroptosis | Testing granzyme-gasdermin axes |
| Bioinformatics analysis | Pathway enrichment and network inference | Interpreting screen and omics data |
Flow cytometry and viability assays
Flow cytometry with Annexin V/propidium iodide or caspase-1/gasdermin staining can quantify pyroptotic death in cytotoxic T cells. LDH release assays measure membrane rupture, a hallmark of pyroptosis. These methods are widely used to assess GSDME- and GSDMB-dependent death in lymphocytes and targets.
Live-cell imaging of gasdermin pores
Live-cell imaging with fluorescently tagged gasdermin N-terminal fragments allows visualization of pore formation and membrane permeabilization in real time. This approach has been used to study GSDME and GSDMB activation during pyroptosis. It is particularly useful for distinguishing pyroptosis from apoptosis in cytotoxic T cells.
Transcriptomics and cytokine profiling
RNA sequencing of cytotoxic T cells undergoing pyroptosis can reveal transcriptional programs and inflammatory signatures. Cytokine profiling for IL-1β and IL-18 confirms pyroptotic release. Single-cell RNA sequencing of decidual CD8+ T cells has identified altered immune function in pregnancy loss.
CRISPR screens and functional genomics
Genome-wide CRISPR knockout screens can identify genes required for cytotoxic T cell pyroptotic death. Focused screens targeting gasdermins, granzymes and immune checkpoints are valuable for dissecting the pathway. Bioinformatics analysis of screen hits can prioritize candidates for validation.
How CRISPR Can Be Used to Study GO:1902483 cytotoxic T cell pyroptotic cell death
Knockout
CRISPR knockout of GSDME, GSDMB, GZMA or GZMB in cytotoxic T cells or target cells can determine which gasdermin and granzyme genes are required for pyroptotic death. Such models have been used to show that GSDME suppresses tumour growth by activating anti-tumour immunity and that granzyme A cleaves GSDMB to trigger pyroptosis.
Point Mutation
Point-mutation knock-in of cleavage sites in GSDME or GSDMB can block granzyme-mediated processing without deleting the gene, allowing precise dissection of proteolytic activation. This approach is valuable for distinguishing pore-forming function from other gasdermin activities.
Knock-in
Tagged knock-in of GSDME or GSDMB with fluorescent or epitope tags enables tracking of cleavage and pore formation in live cells. Knock-in of PD-1 variants can test checkpoint regulation of T cell-mediated pyroptosis in autoimmune liver disease models.
Overexpression
Overexpression of GSDME or GSDMB in cytotoxic T cells or tumour cells can enhance pyroptosis and anti-tumour immunity. Clofarabine-induced GSDME-related pyroptosis and CD8+ T-cell antitumour activity illustrate the therapeutic potential of enhancing this pathway.
How EDITGENE Supports cytotoxic T cell pyroptotic cell death Research
Researchers studying cytotoxic T cell pyroptotic cell death-related genes often need to determine whether a candidate gene is causally involved in gasdermin-dependent death, inflammatory cytokine release or immune regulation. EDITGENE provides CRISPR-based cell model services that enable precise knockout, point mutation, knock-in and overexpression of genes such as GSDME, GSDMB, GZMA, GZMB and PDCD1 in cytotoxic T cell and target cell backgrounds.
Contact EDITGENE today to design your custom CRISPR model for cytotoxic T cell pyroptotic cell death research.
Frequently Asked Questions About cytotoxic T cell pyroptotic cell death
What is GO:1902483 cytotoxic T cell pyroptotic cell death?
GO:1902483 is a Gene Ontology biological process term describing a pyroptotic cell death process that occurs in a cytotoxic T cell, typically involving gasdermin pore formation and inflammatory cytokine release.
What genes are involved in cytotoxic T cell pyroptotic cell death?
Key genes include GSDME, GSDMB, GZMA, GZMB, PDCD1 (PD-1), CASP1, CASP3, STING1 and TP53, based on published functional studies.
How is cytotoxic T cell pyroptotic cell death different from apoptosis?
Pyroptosis is a lytic, gasdermin-dependent death with membrane pore formation and inflammatory release, whereas apoptosis is typically non-lytic and caspase-dependent; the term's synonyms include apoptotic process but the defining mechanism is pyroptotic.
Which granzymes trigger pyroptosis in cytotoxic T cells?
Granzyme A cleaves GSDMB and granzyme B can activate GSDME, both of which can trigger pyroptosis in lymphocytes and target cells.
What role does GSDME play in anti-tumour immunity?
GSDME suppresses tumour growth by activating anti-tumour immunity, and its cleavage drives pyroptotic death that can enhance CD8+ T-cell antitumour activity.
Is cytotoxic T cell pyroptotic cell death involved in autoimmune disease?
Yes, PD-1+CD8+ T cell-mediated hepatocyte pyroptosis promotes progression of murine autoimmune liver disease, linking this process to autoimmunity.
How can I study cytotoxic T cell pyroptotic cell death in the lab?
Common methods include flow cytometry, LDH release assays, live-cell imaging of gasdermin pores, cytokine profiling, RNA sequencing and CRISPR screens.
What CRISPR models are useful for studying this process?
Knockout, point-mutation knock-in, tagged knock-in and overexpression models of GSDME, GSDMB, granzymes and PD-1 are widely used to dissect the pathway.
Does cytotoxic T cell pyroptotic cell death occur in pregnancy complications?
Enrichment of decidual CD11c+CD8+ T cells with altered immune function has been observed in early pregnancy loss, suggesting a role for cytotoxic T cell death pathways.
What is the relationship between pyroptosis and infection control?
Distinct cell death pathways induced by granzymes collectively protect against intestinal Salmonella infection, highlighting the importance of pyroptosis in host defence.
Conclusion
GO:1902483 cytotoxic T cell pyroptotic cell death is a specialized biological process that connects gasdermin biology, granzyme-mediated killing and immune regulation. Its relevance spans cancer immunotherapy, autoimmune liver disease, pregnancy loss and infection, making it a high-priority area for mechanistic and translational research. By combining CRISPR knockout, point-mutation, knock-in and overexpression models with functional assays and bioinformatics, researchers can dissect the causal roles of GSDME, GSDMB, granzymes and checkpoint genes in this process. EDITGENE provides end-to-end support for such studies, from cell model generation to library screening and data analysis.
References
- 1. Zhang Z et al.. 2020. Gasdermin E suppresses tumour growth by activating anti-tumour immunity.. Nature 579(7799):415-420 PMID: 32188940
- 2. Zhou Z et al.. 2020. Granzyme A from cytotoxic lymphocytes cleaves GSDMB to trigger pyroptosis in target cells.. Science 368(6494) PMID: 32299851
- 3. Wrońska K et al.. 2024. The Role of the Immune System in the Course of Hashimoto's Thyroiditis: The Current State of Knowledge.. Int J Mol Sci 25(13) PMID: 38999993
- 4. Long J et al.. 2025. PD-1(+)CD8(+) T Cell-Mediated Hepatocyte Pyroptosis Promotes Progression of Murine Autoimmune Liver Disease.. Adv Sci (Weinh) 12(1):e2407284 PMID: 39494472
- 5. Wu J et al.. 2025. Clofarabine induces tumor cell apoptosis, GSDME-related pyroptosis, and CD8(+) T-cell antitumor activity via the non-canonical P53/STING pathway.. J Immunother Cancer 13(2) PMID: 39915005
- 6. Guo L et al.. 2025. Enrichment of decidual CD11c + CD8 + T cells with altered immune function in early pregnancy loss.. Nat Commun 16(1):6678 PMID: 40691460
- 7. Chawla AS et al.. 2024. Distinct cell death pathways induced by granzymes collectively protect against intestinal Salmonella infection.. Mucosal Immunol 17(6):1242-1255 PMID: 39137883
- 8. Chu T et al.. 2026. Arachidonic acid induces pyroptosis via a non-autophagic function of mitophagy and enhances immunotherapy in a PDAC model.. Nat Commun 17(1):1545 PMID: 41519804
